On Nov. 2, PDL Biopharma
- Revenues rose by 44.4% to $111.4 million, thanks to an increase in Cardene IV sales and strong partner-driven royalties.
- Net loss came in at $6.7 million.
- EPS improved and stood at -$0.06 per share.
- Operating margin and net margin have improved by 48.48% and 52.52%, respectively, thanks to the rise in revenue and fall in costs.
- The company is currently a five-star stock in Motley Fool CAPS.
(Figures in millions, except per-share data)
Income Statement Highlights
|
Avg. Est. |
Q3 2006 |
Q3 2005 |
Change |
|
|---|---|---|---|---|
|
Sales |
$104.1 |
$111.4 |
$77.1 |
44.4% |
|
Net Profit* |
-- |
($6.7) |
($45.2) |
N/A |
|
EPS |
($0.01) |
($0.06) |
($0.43) |
N/A |
|
Diluted Shares |
-- |
113.9 |
105.3 |
8.2% |
Get back to basics with a look at the income statement.
Margin Checkup
|
Q3 2006 |
Q3 2005 |
Change* |
|
|---|---|---|---|
|
Gross Margin |
84.35% |
71.21% |
13.14 |
|
Operating Margin |
(7.06%) |
(55.54%) |
48.48 |
|
Net Margin |
(6.04%) |
(58.56%) |
52.52 |
Margins are the earnings engine. See how they work.
Balance Sheet Highlights
|
Assets |
Q3 2006 |
Q3 2005 |
Change |
|---|---|---|---|
|
Cash + ST Invest. |
$422.3 |
$325.9 |
29.6% |
|
Accounts Rec. |
No Data |
$17.9 |
No Data |
|
Inventory |
No Data |
$18.7 |
No Data |
|
Liabilities |
Q3 2006 |
Q3 2005 |
Change |
|---|---|---|---|
|
Accounts Payable |
No Data |
$11.0 |
No Data |
|
Long-Term Debt |
No Data |
$508.1 |
No Data |
Learn the ways of the balance sheet.
Cash Flow Highlights
|
YTD 2006 |
YTD 2005 |
Change |
|
|---|---|---|---|
|
Cash From Ops. |
$73.0 |
$13.6 |
438.6% |
|
Capital Expenditures |
No Data |
$9.3 |
N/A |
|
Free Cash Flow |
No Data |
$22.3 |
N/A |
Find out why Fools always follow the money.
Related Companies:
-
Amylin Pharmaceuticals
(NASDAQ:AMLN) -
Crucell
(NASDAQ:CRXL) -
ImClone Systems
(NASDAQ:IMCL) -
MedImmune
(NASDAQ:MEDI) -
Medarex
(NASDAQ:MEDX)
Related Foolishness:
PDL Biopharma is a recommendation of Motley Fool Rule Breakers , the newsletter service that tracks companies shaking things up. If you'd like to see what other innovators David Gardner has recommended, try out Rule Breakers free for 30 days .
Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.
